Litcius/Paper detail

Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment

Cong Xia, Cong Xia, Yantao Cai, Shuangyi Ren, Chenglai Xia, Chenglai Xia

2022Frontiers in Pharmacology21 citationsDOIOpen Access PDF

Abstract

The human gut microbiota is associated with the development and progression of colorectal cancer, and manipulation of the gut microbiota is a novel strategy for the prevention and treatment of colorectal cancer. Some bacteria have antitumor activity against colorectal cancer, where specific bacteria can improve the tumor microenvironment, activate immune cells including dendritic cells, helper T cells, natural killer cells, and cytotoxic T cells, and upregulate the secretion of pro-tumor immune cytokines such as interleukin-2 and interferon. In this paper, we summarize some bacteria with potential benefits in colorectal cancer and describe their roles in the tumor microenvironment, demonstrate the application of gut microbes in combination with immunosuppressive agents, and provide suggestions for further experimental studies and clinical practice applications.

Topics & Concepts

Tumor microenvironmentImmune systemColorectal cancerGut floraCytotoxic T cellCancer researchImmunologyMouse model of colorectal and intestinal cancerCancerSecretionMedicineBiologyInternal medicineIn vitroBiochemistryGut microbiota and healthClostridium difficile and Clostridium perfringens researchCancer Immunotherapy and Biomarkers
Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment | Litcius